| 1 | 2529663 | The effect of various anticoagulant/antiplatelet mixtures on determination of plasminogen activator inhibitor, platelet proteins and hemostasis parameters. | Thromb Haemost | 1989 Jun 30 |
1 |
| 2 | 4387664 | [Studies on the endogenous metabolism of mycobacteria. 4. On the influence of ethionamide on the endogenous metabolism of Myc. smegm]. | Z Naturforsch B | 1968 Jul |
1 |
| 3 | 4963957 | [On the inhibition of catalase activity by 2-ethyl-isonicotinic acid thioamide]. | Naturwissenschaften | 1966 Feb |
1 |
| 4 | 6418158 | Haemoglobin potentiates the respiration-inhibitory action of lipoxygenases via its pseudolipohydroperoxidase activity. | Biomed Biochim Acta | 1983 |
1 |
| 5 | 10625209 | Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay. | Semin Thromb Hemost | 1999 |
1 |
| 6 | 12557715 | [A case of advanced gastric adenocarcinoma with mild elevation of serum SCC that responded remarkably to adjuvant chemotherapy of ADM, CDDP, ETP and 5-FU (ACVF)]. | Gan To Kagaku Ryoho | 2003 Jan |
1 |
| 7 | 12869355 | Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. | Arterioscler Thromb Vasc Biol | 2003 Sep 1 |
1 |
| 8 | 15236969 | Crystal structure of the TetR/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance. | J Mol Biol | 2004 Jul 23 |
2 |
| 9 | 15528841 | Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities. | J Pharmacol Sci | 2004 Nov |
1 |
| 10 | 16895935 | Selective intracellular accumulation of the major metabolite issued from the activation of the prodrug ethionamide in mycobacteria. | J Antimicrob Chemother | 2006 Oct |
4 |
| 11 | 18930751 | Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes. | Toxicol Appl Pharmacol | 2008 Dec 15 |
3 |
| 12 | 19589782 | Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism. | J Biol Chem | 2009 Sep 25 |
1 |
| 13 | 19859963 | Axon responses of embryonic stem cell-derived dopaminergic neurons to semaphorins 3A and 3C. | J Neurosci Res | 2010 Apr |
1 |
| 14 | 19861006 | Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis. | Int J Tuberc Lung Dis | 2009 Nov |
1 |
| 15 | 20863819 | Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases. | Chem Biol Interact | 2011 Jun 30 |
1 |
| 16 | 22026918 | Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation. | Mol Microbiol | 2011 Dec |
6 |
| 17 | 22035573 | Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation. | Atherosclerosis | 2012 Jan |
1 |
| 18 | 22098589 | Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. | J Med Chem | 2012 Jan 12 |
1 |
| 19 | 22389470 | HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer. | Mol Cancer Ther | 2012 Apr |
2 |
| 20 | 22520259 | Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor. | Bioorg Med Chem Lett | 2012 May 15 |
1 |
| 21 | 23146620 | Can inhA mutation predict ethionamide resistance? | Int J Tuberc Lung Dis | 2013 Jan |
4 |
| 22 | 23352980 | PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells. | Pharmacol Res | 2013 Apr |
2 |
| 23 | 23476046 | Blood hypomethylation of inflammatory genes mediates the effects of metal-rich airborne pollutants on blood coagulation. | Occup Environ Med | 2013 Jun |
3 |
| 24 | 23826181 | Thrombin generation in the Glasgow Myocardial Infarction Study. | PLoS One | 2013 |
2 |
| 25 | 23926305 | Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. | Blood | 2013 Sep 19 |
2 |
| 26 | 24192167 | Structural and docking studies of potent ethionamide boosters. | Acta Crystallogr C | 2013 Nov |
1 |
| 27 | 24247125 | Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. | Antimicrob Agents Chemother | 2014 |
1 |
| 28 | 24329989 | Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL. | Eur J Haematol | 2014 Mar |
2 |
| 29 | 24566628 | An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition. | Infect Immun | 2014 May |
1 |
| 30 | 24687960 | Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential. | J Exp Med | 2014 Apr 7 |
4 |
| 31 | 24708207 | Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. | Br J Haematol | 2014 Aug |
1 |
| 32 | 25048293 | Hydrogenation of imines catalyzed by trisphosphine-substituted molybdenum and tungsten nitrosyl hydrides and co-catalytic acid. | Chem Asian J | 2014 Oct |
3 |
| 33 | 25199009 | Isoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment. | Int J Tuberc Lung Dis | 2014 Aug |
1 |
| 34 | 25269127 | The development and implementation of, and first years' experience with, a massive/emergency transfusion protocol (damage control hematology protocol) in a Veterans Affairs hospital. | Mil Med | 2014 Oct |
1 |
| 35 | 25767050 | Novel pseudo[2]rotaxanes constructed by the self-assembly of dibenzyl tetramethylene bis-carbamate derivatives and per-ethylated pillar[5]arene. | Chem Commun (Camb) | 2015 Apr 18 |
2 |
| 36 | 26094899 | Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver Microsomes. | Biol Pharm Bull | 2015 |
1 |
| 37 | 26332235 | High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. | PLoS One | 2015 |
1 |
| 38 | 26544630 | Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase. | Eur J Med Chem | 2015 Dec 1 |
4 |
| 39 | 26586461 | Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban. | Int J Hematol | 2016 Feb |
1 |
| 40 | 26586647 | A review of the use of ethionamide and prothionamide in childhood tuberculosis. | Tuberculosis (Edinb) | 2016 Mar |
4 |
| 41 | 26708503 | Suppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells. | Toxicol Appl Pharmacol | 2016 Feb 1 |
7 |
| 42 | 27148573 | Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. | Cold Spring Harb Mol Case Stud | 2015 Oct |
5 |
| 43 | 27393546 | Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis. | Int J Tuberc Lung Dis | 2016 Aug |
2 |
| 44 | 28043598 | Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa. | Int J Mycobacteriol | 2016 Dec |
3 |
| 45 | 28819071 | Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver. | J Pharmacol Exp Ther | 2017 Nov |
2 |
| 46 | 28957755 | Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA). | J Mol Graph Model | 2017 Oct |
1 |
| 47 | 29067094 | Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and <i>NUP214-ABL1</i> fusion: A case report. | Exp Ther Med | 2017 Nov |
2 |
| 48 | 29878384 | Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin-Containing Monooxygenase 3 Maturational Changes Over Time. | J Clin Pharmacol | 2018 Oct |
3 |
| 49 | 30684598 | In vitro dissolution testing of respirable size anti-tubercular drug particles using a small volume dissolution apparatus. | Int J Pharm | 2019 Mar 25 |
4 |
| 50 | 30690726 | Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3. | J Clin Pharmacol | 2019 Jun |
11 |